Literature DB >> 22226893

Nonlinear relationship between body mass index and esophageal acid exposure in the extraesophageal manifestations of reflux.

Muhammad Aslam1, James C Slaughter, Marion Goutte, C Gaelyn Garrett, David Hagaman, Michael F Vaezi.   

Abstract

BACKGROUND & AIMS: Obesity is believed to be an important etiologic factor in gastroesophageal reflux disease. However, it is not clear how obesity might affect esophageal acid exposure in patients with extraesophageal manifestations of reflux.
METHODS: We conducted a cross-sectional study of 223 patients with extraesophageal symptoms suspected of being related to reflux. Participants underwent endoscopy and 48-hour wireless pH testing. The percentage of time at a pH of less than 4 (total, upright, and supine) was measured for each patient, and data were compared with corresponding body mass index (BMI), as continuous and categoric variables (normal, 18.5 to <25; overweight, 25 to <30; and obese, >30). Multivariable linear regression was used to identify variables associated with percentage of total time at a pH less than 4. The primary predictor of interest was BMI; age, sex, esophagitis, and hiatal hernia status were considered potential confounders or precision variables.
RESULTS: Esophageal acid exposure was associated significantly (P < .001) with BMI. The percentage of time at a pH less than 4 and total symptomatic reflux events increased significantly (P = .005) with increasing BMI. The relationship between percentage of time at a pH less than 4 and BMI was nonlinear and S-shaped. With BMI ranges, the percentage of time at a pH less than 4 increased by 0.23% (normal BMI), 0.75% (overweight), and 0.07% (obese) for every 1-kg/m(2) increase in BMI (P < .001).
CONCLUSIONS: Increases in esophageal acid exposure are greatest among overweight patients and plateau in obese patients. The findings have implications for benefit of weight loss in patients with suspected extraesophageal manifestations of gastroesophageal reflux disease.
Copyright © 2012 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22226893     DOI: 10.1016/j.cgh.2011.12.032

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN: 1542-3565            Impact factor:   11.382


  8 in total

Review 1.  The role of obesity in oesophageal cancer development.

Authors:  Elizabeth Long; Ian L P Beales
Journal:  Therap Adv Gastroenterol       Date:  2014-11       Impact factor: 4.409

2.  Functional Gastrointestinal Disorders in Obese Patients. The Importance of the Enrollment Source.

Authors:  Michel Bouchoucha; Marinos Fysekidis; Chantal Julia; Gheorghe Airinei; Jean-Marc Catheline; Gérard Reach; Robert Benamouzig
Journal:  Obes Surg       Date:  2015-11       Impact factor: 4.129

Review 3.  Extra-esophageal manifestations of GERD: who responds to GERD therapy?

Authors:  Rishi D Naik; Michael F Vaezi
Journal:  Curr Gastroenterol Rep       Date:  2013-04

4.  Roux-En-Y gastric bypass following failed fundoplication.

Authors:  Kathleen M Coakley; Steven A Groene; Paul D Colavita; Tanushree Prasad; Dimitris Stefanidis; Amy E Lincourt; Vedra A Augenstein; Keith Gersin; B Todd Heniford
Journal:  Surg Endosc       Date:  2018-01-23       Impact factor: 4.584

5.  No increase in gastric acid secretion in healthy Japanese over the past two decades.

Authors:  Norihisa Ishimura; Yasuko Owada; Masahito Aimi; Tadayuki Oshima; Tomoari Kamada; Kazuhiko Inoue; Hironobu Mikami; Toshihisa Takeuchi; Hiroto Miwa; Kazuhide Higuchi; Yoshikazu Kinoshita
Journal:  J Gastroenterol       Date:  2014-12-14       Impact factor: 7.527

6.  Laparoscopic fundoplication takedown with conversion to Roux-en-Y gastric bypass leads to excellent reflux control and quality of life after fundoplication failure.

Authors:  Dimitrios Stefanidis; Fernando Navarro; Vedra A Augenstein; Keith S Gersin; B Todd Heniford
Journal:  Surg Endosc       Date:  2012-06-13       Impact factor: 4.584

7.  Objective ambulatory pH monitoring and subjective symptom assessment of gastroesophageal reflux disease show type of carbohydrate and type of fat matter.

Authors:  Cihang Gu; Timothy Olszewski; Michael F Vaezi; Kevin D Niswender; Heidi J Silver
Journal:  Therap Adv Gastroenterol       Date:  2022-05-31       Impact factor: 4.802

Review 8.  Role of Non-pharmacological Interventions and Weight Loss in the Management of Gastroesophageal Reflux Disease in Obese Individuals: A Systematic Review.

Authors:  Maria Mukhtar; Mohammed J Alzubaidee; Raga Sruthi Dwarampudi; Sheena Mathew; Sumahitha Bichenapally; Vahe Khachatryan; Asmaa Muazzam; Chandani Hamal; Lakshmi Sai Deepak Reddy Velugoti; Godfrey Tabowei; Greeshma N Gaddipati; Safeera Khan
Journal:  Cureus       Date:  2022-08-31
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.